Home » Stocks » Sun BioPharma

Sun BioPharma, Inc. (SNBP)

Stock Price: $2.84 USD -0.02 (-0.70%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 27.30M
Revenue (ttm) n/a
Net Income (ttm) -4.57M
Shares Out 9.61M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $2.84
Previous Close $2.86
Change ($) -0.02
Change (%) -0.70%
Day's Open 2.95
Day's Range 2.79 - 2.95
Day's Volume 34,469
52-Week Range 2.37 - 10.00

More Stats

Market Cap 27.30M
Enterprise Value 25.95M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 9.61M
Float 7.80M
EPS (basic) -0.68
EPS (diluted) -0.70
FCF / Share -0.49
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 4,868
Short Ratio 0.07
Short % of Float 0.06%
Beta 0.11
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 17.25
Revenue n/a
Operating Income -4.75M
Net Income -4.57M
Free Cash Flow -3.30M
Net Cash 1.36M
Net Cash / Share 0.14
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -127.07%
ROE -615.64%
ROIC -1,983.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$9.00*
Low
9.00
Current: $2.84
High
9.00
Target: 9.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue------0.971.230.70
Revenue Growth-------21%76.16%-
Gross Profit------0.420.540.15
Operating Income-4.32-3.89-6.02-5.17-5.44-3.45-0.190.28-0.10
Net Income-6.20-5.91-10.37-5.11-4.93-3.53-0.210.25-0.14
Shares Outstanding5.704.663.573.111.410.510.150.150.15
Earnings Per Share-1.09-1.27-2.91-1.65-3.50-6.90-1.501.70-1.00
Operating Cash Flow-2.74-2.39-3.40-2.40-3.90-3.34-35.3937.11-73.04
Capital Expenditures-------5.12--9.53
Free Cash Flow-2.74-2.39-3.40-2.40-3.90-3.34-40.5137.11-82.57
Cash & Equivalents2.451.410.150.440.932.150.100.260.07
Total Debt0.860.351.833.283.253.300.580.590.57
Net Cash / Debt1.591.06-1.67-2.84-2.32-1.15-0.48-0.33-0.50
Assets3.141.900.770.881.732.480.530.610.25
Liabilities1.761.634.465.524.413.790.670.650.66
Book Value1.390.27-3.69-4.64-2.68-1.32-0.14-0.04-0.40
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Sun BioPharma, Inc.
Country United States
Employees 4
CEO Jennifer K. Simpson

Stock Information

Ticker Symbol SNBP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: SNBP

Description

Sun BioPharma, a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase 1a/1b clinical trial for the treatment of patients with pancreatic cancer. The company has scientific collaborations with pancreatic disease experts Cedars Sinai Medical Center in Los Angeles, the University of Miami; the University of Florida; the Austin Health Cancer Trials Centre in Melbourne, Australia; the Ashford Cancer Centre in Adelaide, Australia; and the Blacktown Cancer and Haematology Centre in Sydney, Australia. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota.